Immune activation induced by FOLR2+ decidual macrophage deficiency impairs decidualization and angiogenesis in spontaneous abortion - Report - MDSpire

Immune activation induced by FOLR2+ decidual macrophage deficiency impairs decidualization and angiogenesis in spontaneous abortion

  • By

  • Si-Man Chen

  • Meng-Ying Li

  • Yi-Xing Yang

  • Nan Liu

  • Xiao-Yan Cao

  • Hong-Bo Zhao

  • Xiao-Yong Zhu

  • Ming-Qing Li

  • Feng Xie

  • June 23, 2026

  • 0 min

Share

Deficiency of FOLR2+ Decidual Macrophages Disrupts Immune Activation

Overview

This study identifies a significant reduction in FOLR2+ macrophages in the decidua of women experiencing recurrent spontaneous abortion (RSA), which correlates with increased inflammatory signaling and impaired angiogenesis.

Background

Recurrent spontaneous abortion (RSA) affects a notable percentage of women. Understanding the immune mechanisms at the maternal-fetal interface is essential for addressing RSA, as dysregulation in this area can lead to pregnancy failure. Decidual macrophages, particularly the FOLR2+ subset, are critical for maintaining immune tolerance and facilitating successful pregnancy.

Data Highlights

No numerical data available in the source material.

Key Findings

  • FOLR2+ macrophages exhibit an M2-like immunoregulatory phenotype in the decidua.
  • In RSA cases, both FOLR2 expression and the proportion of FOLR2+ macrophages are significantly reduced.
  • Reduced FOLR2+ macrophages are associated with increased inflammatory signaling and impaired angiogenesis.
  • FOLR2 overexpression enhances immunoregulatory and pro-angiogenic properties in macrophages.
  • FOLR2 silencing leads to increased inflammatory responses and impaired angiogenesis.
  • Reciprocal interactions between decidual stromal cells and FOLR2+ macrophages promote decidualization and pregnancy maintenance.

Clinical Implications

The findings highlight the importance of FOLR2+ macrophages in RSA.

Conclusion

The study emphasizes the role of FOLR2+ macrophages in immune regulation at the maternal-fetal interface.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Recurrent pregnancy loss: a committee opinion (2026) | American Society for Reproductive Medicine | ASRM
  6. Recurrent Pregnancy Loss
  7. Recurrent pregnancy loss: a committee opinion (2026) | American Society for Reproductive Medicine | ASRM
  8. Recurrent Pregnancy Loss
  9. Recurrent Miscarriage (Green-top Guideline No. 17) | RCOG
  10. Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta‐analysis - Zhao - 2024 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library
  11. Frontiers | Efficacy of therapeutic interventions for idiopathic recurrent pregnancy loss: a systematic review and network meta-analysis

Original Source(s)

Related Content